Cephaloridine. Studies of therapeutic activity and untoward effects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002509:Cephaloridine / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007239:Infections / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D002509:Cephaloridine